Evolocumab (Repatha (R))

被引：0
|
作者：
Turecek, Claudia [1 ]
机构：
[1] Prinz Eugen Str 8-10, A-1040 Vienna, Austria
来源：
JOURNAL FUR KARDIOLOGIE | 2016年 / 23卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [41] A CASE OF LIVER ENZYME DERANGEMENT WITH EVOLOCUMAB
    Almazrouei, R.
    Alkaabi, F.
    Walji, S.
    Scott, J.
    Cegla, J.
    ATHEROSCLEROSIS, 2018, 275 : E230 - E230
  • [42] Evolocumab (AMG 145) for primary hypercholesterolemia
    Langslet, Gisle
    Emery, Maurice
    Wasserman, Scott M.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (05) : 477 - 488
  • [43] Effect of Evolocumab on Coronary Plaque Composition
    Nicholls, Stephen J.
    Puri, Rishi
    Anderson, Todd
    Ballantyne, Christie M.
    Cho, Leslie
    Kastelein, John J. P.
    Koenig, Wolfgang
    Somaratne, Ransi
    Kassahun, Helina
    Yang, Jingyuan
    Wasserman, Scott M.
    Honda, Satoshi
    Shishikura, Daisuke
    Scherer, Daniel J.
    Borgman, Marilyn
    Brennan, Danielle M.
    Wolski, Kathy
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (17) : 2012 - 2021
  • [44] Evolocumab in Children with Heterozygous Familial Hypercholesterolemia
    de Ferranti, Sarah D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1385 - 1386
  • [45] Cognitive Function in a Randomized Trial of Evolocumab
    Giugliano, Robert P.
    Mach, Francois
    Zavitz, Kenton
    Kurtz, Christopher
    Im, Kyungah
    Kanevsky, Estella
    Schneider, Jingjing
    Wang, Huei
    Keech, Anthony
    Pedersen, Terje R.
    Sabatine, Marc S.
    Sever, Peter S.
    Robinson, Jennifer G.
    Honarpour, Narimon
    Wasserman, Scott M.
    Ott, Brian R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 633 - 643
  • [46] Cognitive Function in a Randomized Trial of Evolocumab Reply
    Reck, Martin
    Rabe, Klaus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1999 - 1999
  • [47] Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Tousoulis, Dimitris
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : 236 - 237
  • [48] Use of evolocumab in a patient with homozygous familial hypercholesterolemia
    Negri, E. A.
    Trenti, C.
    Fasano, T.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 132 - 132
  • [49] Management of dyslipidaemia with evolocumab in kidney transplant recipients
    Manuel Amaro, Jose
    Villanego, Florentino
    Orellana Chavez, Cristhian
    Alberto Vigara, Luis
    Alonso, Marta
    Garcia Alvarez, Teresa
    Mazuecos Blanca, Maria Auxiliadora
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1637 - I1638
  • [50] Evolocumab and Outcomes in Patients With Peripheral Artery Disease
    Bonaca, Marc P.
    Nault, Patrice
    Giugliano, Robert P.
    Keech, Anthony C.
    Pineda, Armando Lira
    Kanevsky, Estella
    Murphy, Sabina A.
    Jukema, J. Wouter
    Lewis, Basil S.
    Tokgozoglu, Lale
    Somaratne, Ransi
    Server, Peter S.
    Pedersen, Terje R.
    Sabatine, Marc S.
    CIRCULATION, 2017, 136 (24) : E451 - E452
12345